Article Text

other Versions

PDF
Galectin-1 expression is associated with tumour immunity and prognosis in gingival squamous cell carcinoma
  1. Yuri Noda1,
  2. Mitsunobu Kishino1,
  3. Sunao Sato1,
  4. Katsutoshi Hirose1,
  5. Manabu Sakai2,
  6. Yasuo Fukuda2,
  7. Shumei Murakami3,
  8. Satoru Toyosawa1
  1. 1Department of Oral Pathology, Osaka University Graduate School of Dentistry, Suita, Japan
  2. 2Clinical Laboratory, Osaka University Dental Hospital, Suita, Japan
  3. 3Department of Oral and Maxillofacial Radiology, Osaka University Graduate School of Dentistry, Suita, Japan
  1. Correspondence to Dr Mitsunobu Kishino, Department of Oral Pathology, Osaka University Graduate School of Dentistry, 1-8, Yamadaoka, Suita, Osaka 565-0871, Japan; mkishino{at}dent.osaka-u.ac.jp

Abstract

Aims Galectin-1 (Gal-1) is a β-galactoside-binding protein that overexpresses in cancer and plays pivotal roles in tumour progression. Gal-1 regulates angiogenesis and invasiveness, and suppresses tumour immunity by inducing T cell apoptosis. Several studies have examined the relationship between Gal-1 and tumour immunosuppression in vivo, but they have not examined the clinicopathological relationship between Gal-1 expression and apoptotic T cell number in human tissue. In this study, we investigated the association between Gal-1 expression and apoptotic T cells of gingival squamous cell carcinoma (GSCC), as well as other clinicopathological factors.

Methods Immunohistochemical investigation of 80 GSCC specimens using anti-Gal-1, anti-CD3, anti-CD4, anti-CD8, anti-CD34, antipodoplanin and anticleaved caspase-3 (CC-3) antibodies was performed. Relative expression levels of CD3 and CC-3, as well as CD8 and CC-3 were assessed simultaneously by double immunostaining. Gal-1 expression and T cell apoptosis were evaluated in 6 high-power fields (3 in the tumour and 3 in the stroma).

Results Gal-1 expression in GSCC was significantly correlated with T cell infiltration (p=0.036), and apoptosis of CD3+ and CD8+ T cells (p<0.001). Moreover, Gal-1 expression was significantly correlated with lymph node metastasis (p=0.021), histological differentiation (p<0.001) and overall survival rate (p=0.021).

Conclusions These findings suggest that Gal-1 plays an important role in immune escape of GSCC cells, and Gal-1 expression level may be a useful clinicopathological prognostic marker for GSCC.

  • ORAL PATHOLOGY
  • IMMUNOHISTOCHEMISTRY
  • CARCINOMA

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.